379 related articles for article (PubMed ID: 15035679)
21. Potential risks and benefits of phytoestrogen-rich diets.
Cassidy A
Int J Vitam Nutr Res; 2003 Mar; 73(2):120-6. PubMed ID: 12747219
[TBL] [Abstract][Full Text] [Related]
22. Phyto-oestrogens and bone health.
Coxam V
Proc Nutr Soc; 2008 May; 67(2):184-95. PubMed ID: 18412992
[TBL] [Abstract][Full Text] [Related]
23. Phyto-oestrogens and cancer.
Adlercreutz H
Lancet Oncol; 2002 Jun; 3(6):364-73. PubMed ID: 12107024
[TBL] [Abstract][Full Text] [Related]
24. Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice.
Ju YH; Fultz J; Allred KF; Doerge DR; Helferich WG
Carcinogenesis; 2006 Apr; 27(4):856-63. PubMed ID: 16399773
[TBL] [Abstract][Full Text] [Related]
25. Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings.
Messina M; McCaskill-Stevens W; Lampe JW
J Natl Cancer Inst; 2006 Sep; 98(18):1275-84. PubMed ID: 16985246
[TBL] [Abstract][Full Text] [Related]
26. Phyto-oestrogens.
Duncan AM; Phipps WR; Kurzer MS
Best Pract Res Clin Endocrinol Metab; 2003 Jun; 17(2):253-71. PubMed ID: 12787551
[TBL] [Abstract][Full Text] [Related]
27. Phytoestrogens and prostate cancer risk.
Ganry O
Prev Med; 2005 Jul; 41(1):1-6. PubMed ID: 15916986
[TBL] [Abstract][Full Text] [Related]
28. Phytoestrogens and breast cancer: a complex story.
Helferich WG; Andrade JE; Hoagland MS
Inflammopharmacology; 2008 Oct; 16(5):219-26. PubMed ID: 18815740
[TBL] [Abstract][Full Text] [Related]
29. Implications of phytoestrogen intake for breast cancer.
Duffy C; Perez K; Partridge A
CA Cancer J Clin; 2007; 57(5):260-77. PubMed ID: 17855484
[TBL] [Abstract][Full Text] [Related]
30. Breast cancer: dietary and environmental oestrogens.
Clarke R; Hilakivi-Clarke L; Trock B
Biologist (London); 2001 Feb; 48(1):21-6. PubMed ID: 11178620
[TBL] [Abstract][Full Text] [Related]
31. Phytoestrogen intake and prostate cancer: a case-control study using a new database.
Strom SS; Yamamura Y; Duphorne CM; Spitz MR; Babaian RJ; Pillow PC; Hursting SD
Nutr Cancer; 1999; 33(1):20-5. PubMed ID: 10227039
[TBL] [Abstract][Full Text] [Related]
32. Role of mammalian lignans in the prevention and treatment of prostate cancer.
McCann MJ; Gill CI; McGlynn H; Rowland IR
Nutr Cancer; 2005; 52(1):1-14. PubMed ID: 16090998
[TBL] [Abstract][Full Text] [Related]
33. Phyto-oestrogens and colorectal cancer risk: a systematic review and dose-response meta-analysis of observational studies.
Jiang R; Botma A; Rudolph A; Hüsing A; Chang-Claude J
Br J Nutr; 2016 Dec; 116(12):2115-2128. PubMed ID: 28091359
[TBL] [Abstract][Full Text] [Related]
34. Prevention of osteopaenia by phyto-oestrogens: animal studies.
Coxam V
Br J Nutr; 2003 Jun; 89 Suppl 1():S75-85. PubMed ID: 12725657
[TBL] [Abstract][Full Text] [Related]
35. Dietary phyto-oestrogens and the risk of ovarian and endometrial cancers: findings from two Australian case-control studies.
Neill AS; Ibiebele TI; Lahmann PH; Hughes MC; Nagle CM; Webb PM;
Br J Nutr; 2014 Apr; 111(8):1430-40. PubMed ID: 24331201
[TBL] [Abstract][Full Text] [Related]
36. Soy product and isoflavone consumption in relation to prostate cancer in Japanese men.
Kurahashi N; Iwasaki M; Sasazuki S; Otani T; Inoue M; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):538-45. PubMed ID: 17337648
[TBL] [Abstract][Full Text] [Related]
37. A comparative study of growth-inhibitory effects of isoflavones and their metabolites on human breast and prostate cancer cell lines.
Xiang H; Schevzov G; Gunning P; Williams HM; Silink M
Nutr Cancer; 2002; 42(2):224-32. PubMed ID: 12416264
[TBL] [Abstract][Full Text] [Related]
38. Reduced isoflavone metabolites formed by the human gut microflora suppress growth but do not affect DNA integrity of human prostate cancer cells.
Raschke M; Wähälä K; Pool-Zobel BL
Br J Nutr; 2006 Sep; 96(3):426-34. PubMed ID: 16925846
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of isoflavones and lignans on invasiveness of MDA-MB-231 breast cancer cells in vitro.
Magee PJ; McGlynn H; Rowland IR
Cancer Lett; 2004 May; 208(1):35-41. PubMed ID: 15105043
[TBL] [Abstract][Full Text] [Related]
40. Phytoestrogens: end of a tale?
Sirtori CR; Arnoldi A; Johnson SK
Ann Med; 2005; 37(6):423-38. PubMed ID: 16203615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
